Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| aTYR PHARMA INC | 22,001 | reported | 06 May 2015 | tx 1+22,001 |
| LogicBio Therapeutics, Inc. | 0 | reported | 16 Nov 2022 | tx 12+1,247,157−1,159,767 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 253,811 | — | |
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 547,000 | — | deriv |
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 328,000 | — | deriv |
| 01 Mar 2022 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 328,000 | 0.00 USD | deriv |
| 16 Apr 2021 | SALE | LogicBio Therapeutics, Inc. | 7,542 | 5.73 USD | |
| 15 Apr 2021 | EXERCISE | LogicBio Therapeutics, Inc. | 23,414 | — | |
| 15 Apr 2021 | EXERCISE | LogicBio Therapeutics, Inc. | 23,414 | 0.00 USD | deriv |
| 23 Feb 2021 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 282,804 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 23,414 | 0.00 USD | deriv |
| 11 Feb 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 222,000 | 0.00 USD | deriv |
| 18 Oct 2018 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 212,525 | 0.00 USD | deriv |
| 06 May 2015 | GRANT_AWARD | aTYR PHARMA INC | 22,001 | — | deriv |